Mechanism of non-steroidal anti-androgen-induced liver injury: Reactive metabolites of flutamide and bicalutamide activate inflammasomes.

[1]  Y. Ijiri,et al.  Regorafenib and reactive metabolite of sunitinib activate inflammasomes: Implications for multi tyrosine kinase inhibitor-Iiduced immune related adverse events. , 2022, Die Pharmazie.

[2]  Y. Ijiri,et al.  Amiodarone, Unlike Dronedarone, Activates Inflammasomes via Its Reactive Metabolites: Implications for Amiodarone Adverse Reactions. , 2021, Chemical research in toxicology.

[3]  Huimei Wu,et al.  Dexamethasone alleviate allergic airway inflammation in mice by inhibiting the activation of NLRP3 inflammasome. , 2019, International immunopharmacology.

[4]  J. Uetrecht,et al.  The 2-Hydroxyiminostilbene Metabolite of Carbamazepine or the Supernatant from Incubation of Hepatocytes with Carbamazepine Activates Inflammasomes: Implications for Carbamazepine-Induced Hypersensitivity Reactions , 2019, Drug Metabolism and Disposition.

[5]  A. Shonhai,et al.  Heat Shock Proteins as Immunomodulants , 2018, Molecules.

[6]  A. Mahadevan,et al.  HSP60 critically regulates endogenous IL-1β production in activated microglia by stimulating NLRP3 inflammasome pathway , 2018, Journal of Neuroinflammation.

[7]  H. Mukai,et al.  Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer , 2017, Cancer Chemotherapy and Pharmacology.

[8]  J. Uetrecht,et al.  Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes. , 2017, Chemical research in toxicology.

[9]  J. Uetrecht,et al.  How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction. , 2017, Chemical research in toxicology.

[10]  J. Mao,et al.  In vitro and in vivo characterization of CYP inhibition by 1‐aminobenzotriazole in rats , 2016, Biopharmaceutics & drug disposition.

[11]  Frank Tacke,et al.  Immunology in the liver — from homeostasis to disease , 2016, Nature Reviews Gastroenterology &Hepatology.

[12]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[13]  T. Ouatas,et al.  Clinical Pharmacokinetic Studies of Enzalutamide , 2015, Clinical Pharmacokinetics.

[14]  L. Glimcher,et al.  Endoplasmic reticulum stress in immunity. , 2015, Annual review of immunology.

[15]  Y. Ijiri,et al.  Human hepatocarcinoma functional liver cell-4 cell line exhibits high expression of drug-metabolizing enzymes in three-dimensional culture. , 2014, Biological & pharmaceutical bulletin.

[16]  S. Larson,et al.  Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Uetrecht,et al.  12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash. , 2013, Chemical research in toxicology.

[18]  B. Rigas,et al.  Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity , 2012, Journal of Pharmacology and Experimental Therapeutics.

[19]  K. Yoshinari,et al.  Role of Enzymatic N-Hydroxylation and Reduction in Flutamide Metabolite-Induced Liver Toxicity , 2009, Drug Metabolism and Disposition.

[20]  R. Beyer,et al.  Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening. , 2007, Chemical research in toxicology.

[21]  F. Boccardo,et al.  Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer , 2005, Cancer Chemotherapy and Pharmacology.

[22]  I. Ikemoto,et al.  Flutamide-induced hepatic dysfunction in relation to steady-state plasma concentrations of flutamide and its metabolites , 2003, Molecular and Cellular Biochemistry.

[23]  J. Uetrecht,et al.  N-OXIDATION OF DRUGS ASSOCIATED WITH IDIOSYNCRATIC DRUG REACTIONS , 2002, Drug metabolism reviews.

[24]  E. Radwanski,et al.  Single and Multiple Dose Pharmacokinetic Evaluation of Flutamide in Normal Geriatric Volunteers , 1989, Journal of clinical pharmacology.

[25]  OUP accepted manuscript , 2021, Toxicological Sciences.

[26]  I. Cockshott.  Bicalutamide , 2004, Clinical pharmacokinetics.

[27]  A. Yamaguchi,et al.  Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer , 2002, Prostate Cancer and Prostatic Diseases.

[28]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.